Biotelemetry, Inc. (NASDAQ:BEAT)

CAPS Rating: 2 out of 5

Results 1 - 20 of 21 : 1 2 Next »

Recs

0
Member Avatar Xience (< 20) Submitted: 7/18/2013 11:57:05 PM : Outperform Start Price: $6.59 BEAT Score: -4.14

Fast burner.... Great products, well do well

Recs

0
Member Avatar stocktheaf (< 20) Submitted: 7/10/2011 4:28:10 PM : Outperform Start Price: $5.13 BEAT Score: -3.55

Profits may turn positive if their collections can stay similar year to year.

Recs

1
Member Avatar GCshipbuilder (< 20) Submitted: 9/22/2010 12:24:16 PM : Outperform Start Price: $4.25 BEAT Score: +1.24

Trading right at its 1 year low and the market isn't going anywhere. Strictly a hunch.

Recs

0
Member Avatar msb345 (< 20) Submitted: 8/5/2010 12:08:31 AM : Outperform Start Price: $5.12 BEAT Score: -30.37

Cardio is just the beginning

Recs

0
Member Avatar lagunabb (21.78) Submitted: 3/25/2010 3:22:55 PM : Outperform Start Price: $7.71 BEAT Score: -71.65

enrollment will go up with healthcare plan. Institutions have been piling in.

Recs

0
Member Avatar spreadsheetV1 (98.75) Submitted: 11/23/2009 1:27:23 AM : Outperform Start Price: $5.12 BEAT Score: -32.79

This met a high level screen to indicate a buy and strong outperform against its peers (other tickers in its industry). My 1st version of this spreadsheet devles deep into the company's balnace sheet and recent income statements, combined with other relevant price data for the company including insider/institutional holdings, short interest, debt levels, etc.
Testing capabilities of this 1st version of my automated, valuation spreadhseet matched with my personal criteria and see how it holds up.

Recs

0
Member Avatar berrygeorge (70.63) Submitted: 11/12/2009 12:46:26 PM : Underperform Start Price: $4.97 BEAT Score: +30.49

This company is unable to collect their bills and has recently rebilled all their customers. Look at their web site. This is a relatively new company with a good concept but no one wants to pay for it.

No end in sight. Will drop before it goes up.

Recs

0
Member Avatar Mrpresident77 (< 20) Submitted: 9/25/2009 2:42:22 PM : Outperform Start Price: $6.95 BEAT Score: -81.20

Making ALL SORTS of money i am not going to avoid this one. I just bought some. And my current rating is better than over 90% of the fool universe i believe is how that is calculated.

Recs

0
Member Avatar MrHappyFinance (< 20) Submitted: 9/17/2009 1:20:03 AM : Outperform Start Price: $7.63 BEAT Score: -87.30

The healthcare industry is ripe for a major technology revolution. Small & mid-cap companies that provide valuable services such as BEAT will stand to benefit for many years to come. Whether they stay independant or get aquired by one of the major healthcare providers, BEAT will make investors happy in the long run.

Recs

0
Member Avatar louislombardi (< 20) Submitted: 8/26/2009 1:29:55 PM : Outperform Start Price: $7.74 BEAT Score: -96.29

big call volume

Recs

0
Member Avatar Boum (< 20) Submitted: 8/22/2009 10:07:24 AM : Outperform Start Price: $14.82 BEAT Score: -170.90

I do a mistake !
I didn't think this stock will perform before long, Looks LIFE.SW, who stay 5 years down after his tumble.
But I hope he will reach 10$ before fluctuate.

Recs

0
Member Avatar Lawrence56 (< 20) Submitted: 7/26/2009 11:52:31 AM : Outperform Start Price: $6.20 BEAT Score: -82.37

Medicare decision is under appeal

Recs

0
Member Avatar jts001 (< 20) Submitted: 7/15/2009 7:39:08 PM : Outperform Start Price: $6.68 BEAT Score: -101.58

Overly beaten down stock with no debt and cash in hand.

Recs

3
Member Avatar TCSekhar (< 20) Submitted: 7/11/2009 12:38:57 PM : Outperform Start Price: $5.81 BEAT Score: -96.24

One-year Price chart with 50-day moving average: 16.29
----------------------------------------------------- -----------
*** NEGATIVE ****
O.K. to buy if stock price is above its 50-day moving average.
THERE ARE 7+ MILLION SHARES SHORT WHICH IS OVER 29% OF TOTAL OUTSTANDING SHARES. THESE SHORTS HAVE TO COVER BY PURCHASING ACTUAL SHARES FROM INSTITUTIONS/INSIDERS/US - AT SOME POINT OF TIME. THIS IS ABSOLUTELY ABNORMAL.
"HENCE THIS NEGATIVE MAY NOT COUNT FOR THIS STOCK"

P/S Ratio: 1.60
--------------------------------
*** POSITIVE ****
O.K. to buy if P/S is less than 10. P/S ratios between 3 and 5 are best for growth stocks. Ratios below 2 reflect value priced stocks.

Cash flow ratio: +11.6
--------------------------------
*** POSITIVE ****
O.K. to buy if Cash Flow per share is a positive number.

Avg Daily Volume: 1.6 Mil
--------------------------------
*** POSITIVE ****
O.K. to buy if Average Daily Volume is 100,000 shares or higher (0.1 mil), and above one million shares is best.

Financial Health Grade: C
--------------------------------
*** POSITIVE ****
O.K. to buy if Financial Health Grade = A, B or C

Growth Grade: C
--------------------------------
*** NEGATIVE ****
O.K. to buy if Growth Grade = “A” or “B”
POTENTIALLY THERE IS SLEEP DISORDER PRODUCT SOMNET COULD BE ANOTHER BREAKTHROUGH FOR ITS GROWTH IN FUTURE. BUT THIS IS UNKNOWN FACTOR YET.

Institutional Ownership: 79%
--------------------------------
*** POSITIVE ****
O.K. to buy if institutions own at least 30% of shares outstanding.

Number of Analysts making Buy/Sell/Hold Recommendations: Yahoo - 8, E*Trade - 13
----------------------------------------------------- -------------------------------------------
*** POSITIVE ****
O.K. to buy if a total of at least four analysts are listed as currently making strong buy, buy, hold, underperform, or sell recommendations. Look only at the total number of analysts making recommendations, not whether there are more buys than holds, etc.

===================================================

Two years ago in Mar 07, they acquired "PDS Heart" for less than $10 Million, and this year in Apr 09, they have acquired "BioTel Inc" for $13 Million paying CASH in full. So most probably their cash and equivalents on hand as of today could be anywhere near to $37 Million.

I believe that few of the institutions who are heavily invested with BEAT weren't too happy with the $4.82 per share deal when the market rate for (BTEL.OB) was below $2. And hence the sell off started. And when Randy figured that the Q2 results weren't going to meet the expectations, and there was already good sell off happening, he started to buy shares to show some internal transactions - to push the share value up. This didn't help that much. Now the shorts were waiting for a chance to nail this stock to ground, and Randy decided to minimize the negative impact of the Q2 results, on July 1st announced the new guidance with the worst possible scenario. This kicked off the sell off which made the stock fall from 14 to 9.

Since March, the shorts (hedges) were playing a major role in bringing this down investing over 90 million dollars assuming there will be huge sell off. Which left them with 5 million short shares until mid of June. I don't have the exact numbers now - but could be close to 6 to 8 million short as of today. Remember this stock was 98% institution and insider owned. Unless other institutions pull out their money, this stock will regain to its original value for sure very easily. The shorts are taking a huge risk.

Talking about future, Obama is towards cost reduction - but, he is also very much into technology. And when it comes to heart related wireless technology and equipments, Cardio has a huge potential with the benefits that they could currently provide with their product and software - which would be very useful for research. Added to that is the sleep disorder product which would hit the market. The increase of sales force is going to drive their business only higher. If Medicaid wouldn't pay for their product, there are thousands of others who currently can afford the extra money to go wireless for their heart treatment - which gives them greater flexibility and added advantages.

And, for now, once the financials come out for Q2 2009 (most probably before July 24th), its going to beat the guidance estimates and will raise. The lows today at 8.3 (shorts may take down further up-to 5 who knows within the next 10 days) will become history.

Recs

0
Member Avatar Bjorn0000 (< 20) Submitted: 7/9/2009 6:46:02 PM : Outperform Start Price: $8.74 BEAT Score: -140.67

My rationale for outperform on this stock is simple.

1. They are still growing by leaps and bounds even in a bad econmy.

2. Their outpatient monitoring device is going to be the wave of the future along side of Obama's healthcare plan.

3. The stock is trading well below it's 52 week low.

4. I believe long term this is a good stock and it is a steal at this price.

Recs

0
Member Avatar turboforpyro (68.35) Submitted: 7/1/2009 12:47:58 PM : Underperform Start Price: $9.85 BEAT Score: +137.82

Going to zero :)

Recs

0
Member Avatar imcurious4 (< 20) Submitted: 5/3/2009 11:11:07 AM : Outperform Start Price: $18.25 BEAT Score: -184.06

GR like kudzoo

Recs

1
Member Avatar pong2015 (85.75) Submitted: 4/17/2009 1:48:12 AM : Underperform Start Price: $23.93 BEAT Score: +198.18

Output from Asterism:
20/17
20/18
=> -1

Recs

0
Member Avatar startitoveragain (< 20) Submitted: 3/26/2009 8:50:37 PM : Outperform Start Price: $28.15 BEAT Score: -216.18

Fundamentals look good, and could possibly be a breakout stock shortly.

Recs

0
Member Avatar LeafKnewBetter (93.83) Submitted: 9/25/2008 9:18:06 PM : Outperform Start Price: $26.50 BEAT Score: -142.02

No real competition in space yet (BHRT will bring a product in the next 6 months). Reimbursement code of $1100 per 12 day period already approved. Millions of patients worldwide need this monitoring.

Results 1 - 20 of 21 : 1 2 Next »

Featured Broker Partners


Advertisement